TABLE 6.

Sensitivity, specificity, PPV, and NPV of 4-Gene-Panel and Gleason score for diagnosis of higher-risk and lower-risk PCa in a retrospective Pca urine cohort.

	14-gene panel			Gleason score
	Positive	Negative	Total	Positive	Negative	Total
Higher risk	36	11	47	9	36	45
Lower risk	7	43	50	0	44	44
Total	43	54	97	9	80	89
Sensitivity (95% CI)	76.60 (88.70–64.49)%			20.00 (31.69–8.31)%
Specificity (95% CI)	86.00 (95.62–76.38)%			100 (100–100)%
PPV (95% CI)	83.72 (94.76–72.69)%			100 (100–100)%
NPV (95% CI)	79.63 (90.37–68.89)%			55.00 (65.90–44.10)%